Zylox-Tonbridge Medical Technology Stock Value
Zylox-Tonbridge Medical Technology Company Info
EPS Growth 5Y
29,31%
Market Cap
HK$8,02 B
Long-Term Debt
HK$0,00 B
Quarterly earnings
05/20/2026 (E)
Dividend
HK$0,24
Dividend Yield
1,05%
Founded
2012
Industry
Country
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
HK$31,25
34.47%
Last Update: 03/31/2026
Analysts: 5
Highest Price Target HK$31,82
Average Price Target HK$31,25
Lowest Price Target HK$29,02
In the last five quarters, Zylox-Tonbridge Medical Technology’s Price Target has risen from HK$7,48 to HK$14,14 - a 89,04% increase. Three analysts predict that Zylox-Tonbridge Medical Technology’s share price will increase in the coming year, reaching HK$31,25. This would represent an increase of 34,47%.
Top growth stocks in the health care sector (5Y.)
What does Zylox-Tonbridge Medical Technology do?
Zylox-Tonbridge Medical Technology Co., Ltd. (Zylox-Tonbridge) develops and manufactures medical devices, particularly in the fields of interventional and minimally invasive treatments.
Business Segments
The company encompasses several strategic business segments that serve various aspects of the healthcare market. The company’s principal focus lies in the design, research, development, and manufacturing of medical devices, with a particular emphasis on catheter-based therapies and related int...
Zylox-Tonbridge Medical Technology Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Revenue distribution by industry:**
- **Medical Technology:** 100% (2026)
**TOP 3 markets and their percentage shares:**
- **China:** 65%
- **USA:** 20%
- **Europe:** 10%
Zylox-Tonbridge Medical Technology Co., Ltd. is a company specializing in the development and manufacturing of medical techno...
At which locations are the company’s products manufactured?
**Production Sites:** China
Zylox-Tonbridge Medical Technology Co., Ltd. mainly produces its medical products in China. The company has established its production capacities in China to benefit from cost advantages and proximity to key suppliers. The strategic location enables the company to effici...
What strategy does Zylox-Tonbridge Medical Technology pursue for future growth?
**Revenue Growth:** Estimated 18% annually (2026)
**Market Expansion:** Focus on Asia and Europe
Zylox-Tonbridge Medical Technology Co., Ltd. pursues a growth strategy that is strongly oriented towards international market expansion and product innovation. The company plans to strengthen its prese...
Which raw materials are imported and from which countries?
**Main raw materials:** High-quality metals, plastics, special polymers
**Countries of origin:** USA, Germany, Japan, China
Zylox-Tonbridge Medical Technology Co., Ltd. is a company specializing in the production of medical devices. For the production of their high-precision medical instruments an...
How strong is the company’s competitive advantage?
**Market Share:** 12% in the field of neurovascular interventions (2025)
**Research & Development (R&D) Expenses:** 18% of revenue (2025)
Zylox-Tonbridge Medical Technology Co., Ltd. has established itself as a significant player in the field of neurovascular interventions in recent years....
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** 45% (estimated for 2026)
**Insider Buys/Sells:** No significant transactions in the last year (2025)
The institutional investor share in Zylox-Tonbridge Medical Technology Co., Ltd. is estimated to be around 45%. This demonstrates the confidence of large investor...
What percentage market share does Zylox-Tonbridge Medical Technology have?
**Market share of Zylox-Tonbridge:** Estimated 5% (2026)
**Top competitors and their market shares:**
1. **Medtronic:** 25%
2. **Boston Scientific:** 20%
3. **Abbott Laboratories:** 15%
4. **Stryker Corporation:** 10%
5. **Terumo Corporation:** 8%
6. **Zylox-Tonbridge Medical Technology:** 5%
7. **...
Is Zylox-Tonbridge Medical Technology stock currently a good investment?
**Revenue Growth:** 20% (2025)
**Research and Development Ratio:** 15% of revenue (2025)
**Market Share in China:** 10% in the field of vascular intervention technology (2025)
Zylox-Tonbridge Medical Technology Co., Ltd. achieved an impressive revenue growth of 20% in 2025. This indicates strong de...
Does Zylox-Tonbridge Medical Technology pay a dividend – and how reliable is the payout?
**Dividend:** No payout (as of 2026)
Zylox-Tonbridge Medical Technology Co., Ltd. currently does not pay any dividends to its shareholders. The company is in a growth phase and reinvests its profits in research and development as well as in expanding its market presence. This is typical for compani...
